Skip to main content
CNSY
NASDAQ Life Sciences

Cerenome Secures Up to $20M Royalty-Based Financing, Extends Runway to 2028

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Healthcare
Sentiment info
Positive
Importance info
8
Price
$2.69
Mkt Cap
$18.898M
52W Low
$2.489
52W High
$23.425
52W Position info
8.1% above low
Off High info
89% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

CNSY is trading near its 52-week low of $2.489 (8.1% above the low).

Summary

Cerenome announced a senior secured financing facility of up to $20 million with 3i, LP, featuring royalty-based repayments. The company received an initial tranche at closing, with additional tranches contingent on milestones. Management states the facility is minimally dilutive and, combined with existing cash and forecasted CNSide sales, extends the cash runway into 2028. This follows the Q2 10-Q disclosing a $9.0M net loss and going concern doubt, making this financing a critical liquidity event. The royalty structure aligns repayment with future revenue, reducing immediate equity dilution but creating ongoing obligations. Watch for the 8-K filing with full terms and milestone details.

Updates

  1. · SEC 8-K — The 8-K details the $21.3M senior secured convertible note financing with 3i, LP: $3.19M initial notes, $2.13M second notes, and $15.96M additional notes, with an initial closing expected September 10, 2026. Initial notes convert at $2.74 per share with a $0.50 floor, and CNSide will pay a 2.5% quarterly royalty capped at 2.5% of outstanding note balance.

At the time of this announcement, CNSY was trading at $2.69 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $18.9M. The 52-week trading range was $2.49 to $23.43. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

CNSY - Latest Insights

CNSY
Nov 16, 2026, 7:45 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.9629
Real-time Price: $0.7107 info
Change: -$0.2522 (-26%) info
Market Cap: $6.953M info
CNSY
Nov 13, 2026, 5:19 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.9601
Real-time Price: $0.7107 info
Change: -$0.2494 (-26%) info
Market Cap: $6.953M info
CNSY
Nov 13, 2026, 5:06 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.970
Real-time Price: $0.7107 info
Change: -$0.2593 (-27%) info
Market Cap: $6.953M info
CNSY
Nov 13, 2026, 4:51 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.9372
Real-time Price: $0.7107 info
Change: -$0.2265 (-24%) info
Market Cap: $6.953M info
CNSY
Nov 04, 2026, 7:30 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.31
Real-time Price: $0.7107 info
Change: -$0.5993 (-46%) info
Market Cap: $6.953M info